総医研ホールディングス is involved in commercializing research results in medical science to contribute to people's health and safety in living.

総医研ホールディングス

Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for physician-led pharmaceutical clinical research, health checkups, and specific health guidance; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.

Soiken Holdings Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 18, 2024 3:09 AM	bf3e3a6c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 18, 2024 3:09 AM	3dd95845
crunchbase trigger	general	Nov 18, 2024 3:09 AM	3123f748
crunchbase profile	general	Nov 18, 2024 4:28 AM	3927950d
li profile	general	Nov 18, 2024 3:09 AM	b125ccb4
translate crunchbase fundingrounds	general
peers	general	Nov 18, 2024 3:09 AM	59a9eead
news basic	general	Nov 18, 2024 3:09 AM	50b2e048
bundesanzeiger	filings
financials download nd	financials
private financials	financials

2385

COM:SOIKEN

総医研ホールディングス

Last Close

138.00

25/11 06:45

Market Cap

4.37B

Beta: -

Volume Today

13.90K

Avg: -